After week-96 of treatment , the ETV group continued to have a higher CVR rate ( 86.0 % vs. LAM : 71.4 % ) , and virology rebound was experienced by significantly less subjects in the ETV group ( 1.2 % vs. LAM : 11.9 % , P = 0.005 ) .